These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31184548)

  • 21. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis.
    Siddique MI; Katas H; Amin MC; Ng SF; Zulfakar MH; Jamil A
    Int J Pharm; 2016 Jun; 507(1-2):72-82. PubMed ID: 27154252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug delivery with topically applied nanoparticles: science fiction or reality.
    Lademann J; Richter H; Meinke MC; Lange-Asschenfeldt B; Antoniou C; Mak WC; Renneberg R; Sterry W; Patzelt A
    Skin Pharmacol Physiol; 2013; 26(4-6):227-33. PubMed ID: 23921109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Predictive Self-Organizing Multicellular Computational Model of Infant Skin Permeability to Topically Applied Substances.
    Stamatas GN; Bensaci J; Greugny E; Kaur S; Wang H; Dizon MV; Cork MJ; Friedman AJ; Oddos T
    J Invest Dermatol; 2021 Aug; 141(8):2049-2055.e1. PubMed ID: 33705796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidermal reaction kinetics following benzol contact].
    Wohlrab W; Wozniak KD
    Derm Beruf Umwelt; 1984; 32(6):211-4. PubMed ID: 6525966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
    Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Skin Permeability and Toxicological Properties of Amorphous Silica Particles.
    Matsuo K; Hirobe S; Okada N; Nakagawa S
    Biol Pharm Bull; 2016; 39(7):1201-5. PubMed ID: 27374294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terpene composited lipid nanoparticles for enhanced dermal delivery of all-trans-retinoic acids.
    Charoenputtakun P; Pamornpathomkul B; Opanasopit P; Rojanarata T; Ngawhirunpat T
    Biol Pharm Bull; 2014; 37(7):1139-48. PubMed ID: 24805206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal epidermal barrier in the pathogenesis of contact dermatitis.
    Proksch E; Brasch J
    Clin Dermatol; 2012; 30(3):335-44. PubMed ID: 22507049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin absorption of inorganic nanoparticles and their toxicity: A review.
    Saweres-Argüelles C; Ramírez-Novillo I; Vergara-Barberán M; Carrasco-Correa EJ; Lerma-García MJ; Simó-Alfonso EF
    Eur J Pharm Biopharm; 2023 Jan; 182():128-140. PubMed ID: 36549398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What do we (need to) know about the kinetic properties of nanoparticles in the body?
    Hagens WI; Oomen AG; de Jong WH; Cassee FR; Sips AJ
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):217-29. PubMed ID: 17868963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic nanoparticles for cutaneous drug delivery--testing in human skin and reconstructed human skin.
    Zoschke C; Schilrreff P; Romero EL; Brandner JM; Schafer-Korting M
    Curr Pharm Des; 2015; 21(20):2784-800. PubMed ID: 25925118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the effects of manufactured nanoparticles on mammalian target organs.
    Wu T; Tang M
    J Appl Toxicol; 2018 Jan; 38(1):25-40. PubMed ID: 28799656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration.
    Huang PH; Hu SC; Lee CW; Yeh AC; Tseng CH; Yen FL
    Int J Nanomedicine; 2016; 11():1615-27. PubMed ID: 27143883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the safety of cosmetic chemicals: Consideration of a flux decision tree to predict dermally delivered systemic dose for comparison with oral TTC (Threshold of Toxicological Concern).
    Williams FM; Rothe H; Barrett G; Chiodini A; Whyte J; Cronin MT; Monteiro-Riviere NA; Plautz J; Roper C; Westerhout J; Yang C; Guy RH
    Regul Toxicol Pharmacol; 2016 Apr; 76():174-86. PubMed ID: 26825378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.
    Lin Z; Monteiro-Riviere NA; Kannan R; Riviere JE
    Nanomedicine (Lond); 2016 Jan; 11(2):107-19. PubMed ID: 26653715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in assessing nanomaterial toxicology: a personal perspective.
    Geraci CL; Castranova V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):569-77. PubMed ID: 20799267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biocompatible nanoparticles for sustained topical delivery of anticancer phytoconstituent quercetin.
    Sahu S; Saraf S; Kaur CD; Saraf S
    Pak J Biol Sci; 2013 Jul; 16(13):601-9. PubMed ID: 24505982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailored dendritic core-multishell nanocarriers for efficient dermal drug delivery: A systematic top-down approach from synthesis to preclinical testing.
    Hönzke S; Gerecke C; Elpelt A; Zhang N; Unbehauen M; Kral V; Fleige E; Paulus F; Haag R; Schäfer-Korting M; Kleuser B; Hedtrich S
    J Control Release; 2016 Nov; 242():50-63. PubMed ID: 27349353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic effects of nanoparticles assessed in vitro and in vivo.
    Cha KE; Myung H
    J Microbiol Biotechnol; 2007 Sep; 17(9):1573-8. PubMed ID: 18062241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.